Untitled Document
Not a member yet? Register for full benefits!

Username
Password
 Using computer models to predict more effective therapies

This story is from the category Health
Printer Friendly Version
Email to a Friend (currently Down)

 

 

Date posted: 14/07/2013

Scientist at Charité – Universitätsmedizin Berlin have used a computer simulation for predicting the effectiveness of various combination therapies for colon tumors. The study has been published in the current issue of the professional journal Molecular Systems Biology*.

In most tumors, the communication between the individual cells is disturbed and the cells permanently receive growth and survival signals. For this reason, drugs are increasingly used in modern tumor therapy that targets those molecules to shut down these faulty signals. Hitherto, however, it has been difficult to predict the success of such a therapy, since the signal molecules are integrated into an extremely complex cellular network, which, moreover, reacts differently for each patient, depending on the mutations the tumor bears.

The research group headed by Nils Blüthgen, Charité Institute of Pathology, has now examined how the interconnection of such a cellular network affects the effectiveness of a therapy. For this purpose, the scientists created computer models to simulate the networks of various colon cancer cells. The models were adapted to quantitative data from cell culture experiments. When analyzing their computer simulations, the researchers discovered that the cellular tumor networks exhibited strong feedback characteristics. This means that the cutting off of a particular signal molecule activates a receptor, which, in turn, then switches on signal paths that favor the survival of the tumor cell. In a further step, the computer model predicted a combination therapy using two drugs, which prevents the activation of survival signals, so making for a more effective therapy. The scientists have tested these predictions on various cell models. “The remarkable thing is that the combination of two therapies is effective with a large number of different mutations, including the mutant oncogene KRAS. This is a gene, which is of key importance for the regulation of growth and differentiation processes, and for which no targeted therapy has been possible up to now”, stated Nils Blüthgen. “However, it is still too early to say whether this behavior detected in the cell culture model can be applied to patients. Here, further investigations are necessary”.

This approach undertaken by the researchers to combine computer models with quantitative data to simulate the behavior of networks is called system biology. It is considered a promising method of examining therapies and diagnostics for complex diseases. “Particularly when investigating the effect of inhibitors in complex networks, it is hardly possible to predict the network’s response without the use of computer models”, according to Blüthgen.

See the full Story via external site: www.alphagalileo.org



Most recent stories in this category (Health):

03/03/2017: Interactive health apps may inspire healthy behaviors, but watch the tone

31/01/2017: Surgical eye robot performs precision-injection in patient with retinal vein occlusion

31/01/2017: Assessment of comatose patients through telemedicine efforts shown to be reliable

12/01/2017: Wearable biosensors can flag illness, Lyme disease, risk for diabetes; low airplane oxygen

31/12/2016: Drone-based blood deliveries in Tanzania to be funded by UK

23/12/2016: Researchers combat antimicrobial resistance using smartphones

14/12/2016: Snapchat spectacles worn by UK surgeon while operating

02/06/2015: Staring Pain in the Face – Software Reads Kids’ Expressions to Measure Pain Levels